High and Low Dose High-intensity Laser Therapy Lateral Epicondylitis

NCT ID: NCT07342426

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-12

Study Completion Date

2026-12-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High-intensity laser therapy has gained increasing attention in recent years as a therapeutic modality. It is a non-invasive treatment that can reduce pain, increase local blood circulation, and promote tissue repair. The higher energy output of high-intensity laser therapy also have deeper tissue penetration. Several studies have investigated the effects of high-intensity laser therapy on lateral epicondylitis, and the existing literature indicates that, compared with other treatment modalities, high-intensity laser therapy is more effective in improving pain and quality of life in patients with lateral epicondylitis.

However, the dosage, duration, and treatment frequency applied in previous studies vary considerably. The therapeutic effects of high-intensity laser therapy may therefore be influenced by treatment dosage. Consequently, the purpose of this study is to compare the effects of two different dosages of high-intensity laser therapy on patients with lateral epicondylitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lateral Epicondylitis High Intensity Laser Therapy Tennis Elbow High Intensity Laser

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conrol group

Placebo high intensity laser therapy with Infarred ray and Transcutaneous electrical nerve stimulator therapy

Group Type PLACEBO_COMPARATOR

Infarred ray therapy system

Intervention Type DEVICE

Using infarred ray therapy applying on affected area for 15 minutes.

Transcutaneous electrical nerve stimulator

Intervention Type DEVICE

Using transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.

Low dosage group

Low dosage High intensity laser with Infarred ray and Transcutaneous electrical nerve stimulator therapy

Group Type EXPERIMENTAL

High intensity laser therapy

Intervention Type DEVICE

Using high-intensity laser therapy applying on the affected area.

Infarred ray therapy system

Intervention Type DEVICE

Using infarred ray therapy applying on affected area for 15 minutes.

Transcutaneous electrical nerve stimulator

Intervention Type DEVICE

Using transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.

High dosage group

High dosage High intensity laser therapy with Infarred ray and Transcutaneous electrical nerve stimulator therapy

Group Type EXPERIMENTAL

High intensity laser therapy

Intervention Type DEVICE

Using high-intensity laser therapy applying on the affected area.

Infarred ray therapy system

Intervention Type DEVICE

Using infarred ray therapy applying on affected area for 15 minutes.

Transcutaneous electrical nerve stimulator

Intervention Type DEVICE

Using transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High intensity laser therapy

Using high-intensity laser therapy applying on the affected area.

Intervention Type DEVICE

Infarred ray therapy system

Using infarred ray therapy applying on affected area for 15 minutes.

Intervention Type DEVICE

Transcutaneous electrical nerve stimulator

Using transcutaneous electrical nerve stimulator on the affected area fior 15 minutes.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients diagnosed with lateral epicondylitis by physician
2. Disease duration of less than three months
3. Adults aged above 18 years with full decision-making capacity

Exclusion Criteria

1. Patients who have received treatments other than standard treatment to the affected area within past three months
2. Patients with contraindication for rehabilitation therapy

1. Photosensitivity
2. Sensory impairment
3. Implanted cardiac pacemaker
4. Pregnancy
5. Malignancy
3. Patients with a history of surgery on the affected elbow
4. Patients with cervical radiculopathy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

TSAI CHENG-TAO Physical Therapy Clinic

Kaohsiung City, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

CHENG-CHANG LU

Role: CONTACT

+886 975357331

MIN-HAO TSAI

Role: CONTACT

+886 908011166

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

CHENG-TAO TSAI

Role: primary

+886 932772196

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KMUHIRB-F(I)-20250361

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.